Insights from 2023 ESMO Asia Annual Meeting

 

Insights from 2023 ESMO Asia Annual Meeting
M

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC Patients Progressed to Atezolizumab + Bevacizumab"

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Mara Persano
By Insights from 2023 ESMO Asia Annual Meeting FEATURING Mara Persano
71 views
January 17, 2024
0 Comments
Login to view comments. Click here to Login
Gastrointestinal
18:31

Enhancing IO Benefit in Upper-Aerodigestive Malignancies - Leveragin…

Insights from 2023 ESMO Asia Annual Meeting

B. Henick

114 views
08:19

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Ol…

Insights from 2023 ESMO Asia Annual Meeting

E. Oki

34 views
08:21

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analyses fo…

Insights from 2023 ESMO Asia Annual Meeting

M. Kudo

60 views
11:13

Leveraging the Molecular Biology of HCC in Optimising Response to Im…

Insights from 2023 ESMO Asia Annual Meeting

S. L. Chan

38 views
06:49

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

71 views
06:53

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Act…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

41 views
06:05

ESMO Asia 2023 Insights: "Long-Term Outcomes of Intraoperative Chemo…

Insights from 2023 ESMO Asia Annual Meeting

J. Taieb

131 views
21:46

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management…

Insights from 2023 ESMO Asia Annual Meeting

M. Ikeda

305 views
18:15

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

173 views
08:56

ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab …

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

136 views
13:51

ESMO Asia 2023 Insights: "Final Results of the RATIONALE-305 Study -…

Insights from 2023 ESMO Asia Annual Meeting

K. Kato

131 views